Form 8-K - Current report:
SEC Accession No. 0001493152-22-017614
Filing Date
2022-06-23
Accepted
2022-06-23 17:22:16
Documents
15
Period of Report
2022-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53215
2 ex10-1.htm EX-10.1 139156
3 ex99-1.htm EX-99.1 15994
4 ex99-1_001.jpg GRAPHIC 11510
  Complete submission text file 0001493152-22-017614.txt   435893

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogen-20220623.xsd EX-101.SCH 2962
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogen-20220623_lab.xml EX-101.LAB 34240
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogen-20220623_pre.xml EX-101.PRE 22361
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3617
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 221036408
SIC: 2834 Pharmaceutical Preparations